arrow
A

Alberto Sánchez-Fueyo

king's college london and king's college hospital
H指数:53
被引数:9,688

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinoma

Nrf2介导的代谢重编程驱动肝细胞癌中调节性T细胞积累

2026-07-130
OA
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study

供者特异性免疫衰老作为成人肝移植后操作耐受的候选生物标志物:一项前瞻性、多中心队列研究的结果

2024-11-012
PRE
Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease

失调的抗氧化信号和受损的线粒体完整性对肝脏疾病中的调节性T细胞功能和活力产生负面影响

2023-09-0117
OAAI
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans

低剂量interleukin-2选择性地扩增循环调节性T细胞,但不能促进人类肝脏同种异体移植耐受

2023-01-0131
OA
Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans

肝移植后供体反应性Treg的选择性减少限制了Treg治疗促进人类同种异体移植耐受

2022-11-0233
PRE
The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study
2022-03-016
OAAI
Non-invasive alloimmune risk stratification of long-term liver transplant recipients

长期肝移植受者的非侵入性同种免疫风险分层

2021-12-0129
OA
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial

预先形成的T细胞同种免疫和HLA eplet不匹配指导肾移植中他克莫司单药治疗的免疫抑制最小化: CELLIMIN试验的结果

2021-08-0128
PREAI